Biotech Outsource Strategies

4 September 2007 / Royal College of Physicians / London / UK

Biotech Outsource Strategies (BOS) is a unique event to bring together international biotech outsource executives and contract research and manufacturing organisations (CRAMs).

The focus for the event is small molecule discovery and early development. The event will be highly appropriate for biotech executives involved in discovery/early development disciplines including pharmacology, in vitro biology, analytical chemistry, medicinal chemistry, early development chemistry and process R&D/early scale up. BOS is primarily a partnering event and is therefore aimed at outsourcing decision makers in these disciplines. In addition to the programme of leading industry speakers you will be able to arrange meetings with niche CRAMs using a partnering software. BOS provides an excellent opportunity to build knowledge, build networks amongst fellow biotech and forge new partnerships with high quality global CRAMs.

For the service industry BOS provides an unparalleled opportunity to meet with new potential clients and forge new collaborations. For further information, programme and current attendee list, please see the BOS forum website (username: delegate and password: london).

Bio2Business is delighted to be working exclusively with Medicon Valley Alliance to bring a Danish-Swedish delegation to BOS. Medicon Valley Alliance biotech members is offered 10 "biotech" delegates passes free of charge on a first come first serve basis. For contract research and manufacturing partners we can present a very competitive sponsorship package only available to Medicon Valley Alliance members (details on request).

For further details, please contact Project Manager Tove Østergaard at MVA or Roger Green at Bio2Business.